Hirofumi Shirakawa
Papers
1
Total Citations
9
H-Index
1
About
Dr. Hirofumi Shirakawa is a leading figure in surgical oncology, with a primary focus on pancreatic cancer treatment and the advancement of minimally invasive surgical techniques. His major contribution lies in pioneering high-level, multi-institutional clinical trials that rigorously compare the oncologic safety of minimally invasive distal pancreatectomy (MIDP) against traditional open surgery. As the principal investigator of the landmark JCOG2202 (LAPAN) study, he is addressing a critical gap in evidence, directly challenging the field to move beyond short-term outcomes and validate the long-term oncologic efficacy of laparoscopic and robotic approaches. This work, already cited 9 times since its 2024 publication, is shaping global surgical standards for pancreatic cancer. Dr. Shirakawa’s research is instrumental in defining the future of safe, evidence-based surgical care, ensuring that technological adoption is matched by rigorous scientific validation for the benefit of patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1